Cross-talk between retinoic acid and interferons: Molecular mechanisms of interaction in acute promyelocytic leukemia cells

Enrico Garattini, Luca Mologni, Isabella Ponzanelli, Mineko Terao

Research output: Contribution to journalArticlepeer-review

Abstract

All-trans retinoic acid (ATRA) and interferons (IFNs) are active anticancer agents. ATRA is capable of inducing complete remission in acute promyelocytic leukemia (APL) patients, whereas IFNα is successfully used in the treatment of the stable phase of chronic myeloid leukemia. ATRA and IFNs have shown synergistic interactions in various experimental conditions and represent a potentially useful therapeutic combination in the treatment of various types of leukemias and solid tumors. The molecular basis of these interactions are poorly understood and need to be elucidated. In this review, we summarize a series of recent observations concerning the molecular mechanisms underlying the cross-talk between the intracellular pathways activated by ATRA and IFNs in APL cells. In APL blasts, IFNs regulate the expression of retinoic acid receptors, and ATRA, in turn, modulates the levels and the state of activation of members of the Jak-STAT second messenger pathway. This demonstrates a two-way interaction between ATRA and IFNs, which leads to cross-modulation of genes normally under the control of the retinoid and the cytokine. These data may be relevant in the context of a rational use of the combination between ATRA and IFNs in the clinical management of myeloid leukemias.

Original languageEnglish
Pages (from-to)467-475
Number of pages9
JournalLeukemia and Lymphoma
Volume30
Issue number5-6
Publication statusPublished - 1998

Keywords

  • All-trans retinoic acid
  • APL
  • Interferons
  • Intracellular signaling
  • Jak-STAT
  • Retinoids

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Cross-talk between retinoic acid and interferons: Molecular mechanisms of interaction in acute promyelocytic leukemia cells'. Together they form a unique fingerprint.

Cite this